These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27197698)

  • 1. Reply to Umberto Capitanio, Paolo Dell'Oglio, Alessandro Larcher, and Francesco Montorsi's Reply to Kazutaka Saito's Words of Wisdom re: Nephron-sparing Techniques Independently Decrease the Risk of Cardiovascular Events Relative to Radical Nephrectomy in Patients with a T1a-T1b Renal Mass and Normal Preoperative Renal Function. Eur Urol. 2016;69:538.
    Saito K
    Eur Urol; 2016 Oct; 70(4):e99. PubMed ID: 27197698
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to Kazutaka Saito's Words of Wisdom re: Nephron-sparing Techniques Independently Decrease the Risk of Cardiovascular Events Relative to Radical Nephrectomy in Patients with a T1a-T1b Renal Mass and Normal Preoperative Renal Function. Eur Urol. 2016;69:538.
    Capitanio U; Dell'Oglio P; Larcher A; Montorsi F
    Eur Urol; 2016 Nov; 70(5):e135. PubMed ID: 27131952
    [No Abstract]   [Full Text] [Related]  

  • 3. Words of Wisdom. Re: Nephron-sparing Techniques Independently Decrease the Risk of Cardiovascular Events Relative to Radical Nephrectomy in Patients with a T1a-T1b Renal Mass and Normal Preoperative Renal Function.
    Saito K
    Eur Urol; 2016 Mar; 69(3):538. PubMed ID: 26867724
    [No Abstract]   [Full Text] [Related]  

  • 4. Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with a T1a-T1b renal mass and normal preoperative renal function.
    Capitanio U; Terrone C; Antonelli A; Minervini A; Volpe A; Furlan M; Matloob R; Regis F; Fiori C; Porpiglia F; Di Trapani E; Zacchero M; Serni S; Salonia A; Carini M; Simeone C; Montorsi F; Bertini R
    Eur Urol; 2015 Apr; 67(4):683-9. PubMed ID: 25282367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: Todd M. Morgan, Dominic Tang, Kelly L. Stratton, et al. Preoperative nutritional status is an important predictor of survival in patients undergoing surgery for renal cell carcinoma. Eur Urol 2011;59:923-8. Re: Umberto Capitanio, Francesco Montorsi. Does preoperative nutritional status affect survival in renal cell carcinoma? The debate continues. Eur Urol 2011;59:929-30.
    Brookman-May S; Burger M; Wieland WF; May M
    Eur Urol; 2011 Nov; 60(5):e45-6; author reply e47. PubMed ID: 21820239
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply to Francesco Montorsi, Alessandro Larcher, and Umberto Capitanio's Letter to the Editor re: Rohann J.M. Correa, Alexander V. Louie, Nicholas G. Zaorsky, et al. The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. Eur Urol Focus. 2019 Jun 24. pii: S2405-4569(19)30157-9. https://doi.org/10.1016/j.euf.2019.06.002. [Epub ahead of print].
    Correa RJM; Louie AV; Zaorsky NG; Lehrer EJ; Ellis R; Ponsky L; Kaplan I; Mahadevan A; Chu W; Swaminath A; Hannan R; Onishi H; Teh BS; Muacevic A; Lo SS; Staehler M; Siva S
    Eur Urol Focus; 2021 Mar; 7(2):404-405. PubMed ID: 31679868
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Maria Carmen Mir, Ithaar Derweesh, Francesco Porpiglia, Homayoun Zargar, Alexandre Mottrie, Riccardo Autorino. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies. Eur Urol 2017;71:606-17.
    Kim JH; Chung BI
    Eur Urol; 2017 Nov; 72(5):e127-e128. PubMed ID: 28545840
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Maria Carmen Mir, Ithaar Derweesh, Francesco Porpiglia, Homayoun Zargar, Alexandre Mottrie, Riccardo Autorino. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies. Eur Urol. 2017;71:606-17.
    Marconi L; MacLennan S; Lam TBL; Canfield SE; Yuan Y; Omar MI; N'Dow J; Sylvester R
    Eur Urol; 2017 Sep; 72(3):e59-e60. PubMed ID: 28629586
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of nephron sparing surgery for metastatic (pM1) renal cell carcinoma.
    Krambeck AE; Leibovich BC; Lohse CM; Kwon ED; Zincke H; Blute ML
    J Urol; 2006 Nov; 176(5):1990-5; discussion 1995. PubMed ID: 17070231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of partial nephrectomy for clinical T1b and T2 renal tumors.
    Lee HJ; Liss MA; Derweesh IH
    Curr Opin Urol; 2014 Sep; 24(5):448-52. PubMed ID: 24921904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reply to Jae Heon Kim and Benjamin I. Chung's Letter to the Editor re: Maria Carmen Mir, Ithaar Derweesh, Francesco Porpiglia, Homayoun Zargar, Alexandre Mottrie, Riccardo Autorino. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies. Eur Urol 2017;71:606-17.
    Mir MC; Derweesh IH; Autorino R
    Eur Urol; 2017 Nov; 72(5):e129-e130. PubMed ID: 28528815
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply to Lorenzo Marconi, Steven MacLennan, Thomas B.L. Lam, et al's Letter to the Editor re: Maria Carmen Mir, Ithaar Derweesh, Francesco Porpiglia, Homayoun Zargar, Alexandre Mottrie, Riccardo Autorino. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies. Eur Urol 2017;71:606-17.
    Derweesh IH; Mir MC; Autorino R
    Eur Urol; 2017 Sep; 72(3):e61-e62. PubMed ID: 28642021
    [No Abstract]   [Full Text] [Related]  

  • 13. Similar functional outcomes after partial nephrectomy for clinical T1b and T1a renal cell carcinoma.
    Iizuka J; Kondo T; Hashimoto Y; Kobayashi H; Ikezawa E; Takagi T; Omae K; Tanabe K
    Int J Urol; 2012 Nov; 19(11):980-6. PubMed ID: 22735049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephron-sparing surgery for renal cell carcinoma in the solitary kidney.
    Berdjis N; Hakenberg OW; Novotny V; Manseck A; Oehlschläger S; Wirth MP
    Scand J Urol Nephrol; 2007; 41(1):10-3. PubMed ID: 17366096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal cell carcinoma: considerations for nephron-sparing surgery.
    Lerner SE; Tsai H; Flanigan RC; Trump DL; Fleischmann J
    Urology; 1995 Apr; 45(4):574-7. PubMed ID: 7716836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elective nephron sparing surgery for renal cell carcinoma larger than 4 cm.
    Pahernik S; Roos F; Röhrig B; Wiesner C; Thüroff JW
    J Urol; 2008 Jan; 179(1):71-4; discussion 74. PubMed ID: 17997423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephron sparing surgery is a feasible and efficient treatment of T1a renal cell carcinoma in kidney transplant: a prospective series from a single center.
    Chambade D; Meria P; Tariel E; Vérine J; De Kerviler E; Peraldi MN; Glotz D; Desgrandchamps F; Mongiat-Artus P
    J Urol; 2008 Nov; 180(5):2106-9. PubMed ID: 18804233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephron sparing surgery for renal tumors: indications, techniques and outcomes.
    Uzzo RG; Novick AC
    J Urol; 2001 Jul; 166(1):6-18. PubMed ID: 11435813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal surgical margin in nephron-sparing surgery for T1b renal cell carcinoma.
    Chen XS; Zhang ZT; Du J; Bi XC; Sun G; Yao X
    Urology; 2012 Apr; 79(4):836-9. PubMed ID: 22305422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re: Vincent Cloutier, Umberto Capitanio, Laurent Zini, et al. Thirty-day mortality after nephrectomy: clinical implications for informed consent. Eur urol 2009;56:998-1005.
    Campodonico F; Capponi G; Maffezzini M
    Eur Urol; 2009 Dec; 56(6):e45-6; author reply e47. PubMed ID: 19307052
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.